Brandtree

Who owns REALBARRIER?

REALBARRIER is owned by Neopharm (South Korea, KRX: 092730).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Evidence: NeoPharm Co., Ltd. Business Report (사업보고서) for fiscal year 2025, filed with DART, 16 March 2026. Last checked .

Key facts

Current owner
NeoPharm Co., Ltd. reported
Owner HQ
🇰🇷 South Korea, Daejeon
Origin
🇰🇷 South Korea, Daejeon
Category
Personal care & beauty › Skin care › Dermocosmetics & clinical skin care
Parent ticker
KRX: 092730
Last verified
· 2 sources

About REALBARRIER

REALBARRIER is Neopharm's dermocosmetic brand for the skin barrier, which the company calls an active skin barrier brand. Its lines are Extreme Procera, built on a blend of four ceramides and approved in Korea as functional for barrier recovery, whitening and wrinkle care; Watery Hyal for hydration; Cicarelief for soothing; and Control-T for oily skin. Neopharm's business report names it with ATOPALM as its main moisturising products.

Ownership timeline of REALBARRIER

  1. Current owner Neopharm [1] reported

Where REALBARRIER sits in Neopharm

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where REALBARRIER sits in Neopharm Tree of 5 brands under Neopharm. Neopharm REALBARRIER ATOPALM Derma:B T'else ZEROID

Open the full Neopharm ownership tree →

See the full Neopharm brand portfolio (5) →

Other brands owned by Neopharm

Neopharm controls 5 brands on Brandtree, 5 of them in personal care & beauty.

Also in personal care & beauty

All Neopharm brands →

Other brands in dermocosmetics & clinical skin care, and who owns them

The 48 brands in dermocosmetics & clinical skin care on Brandtree belong to 27 owners. The largest is Ego Pharmaceuticals, with 9; Neopharm has 2.

BrandOwnerOwner based in
DermAid Ego Pharmaceuticals 🇦🇺 Australia
Biretix Cantabria Labs 🇪🇸 Spain
CeraVe L'Oréal 🇫🇷 France
A-Derma Pierre Fabre 🇫🇷 France
Dermalogica Unilever 🇬🇧 United Kingdom
Minon Daiichi Sankyo Healthcare 🇯🇵 Japan
Alastin Galderma 🇨🇭 Switzerland
Celapi Able C&C 🇰🇷 South Korea

Every brand in dermocosmetics & clinical skin care and its owner →

About the owner: Neopharm

Neopharm is a publicly listed company headquartered in Daejeon, South Korea, founded in 2000. Brandtree records 5 brands under its control, and it is listed as KRX: 092730.

Neopharm is a Daejeon skin care company founded in July 2000 that builds its products on MLE, its own formulation that mimics the lipid structure of healthy skin. It has been listed on KOSDAQ since January 2007. Its largest shareholder is the cosmetics group It's Hanbul, which with related parties held 41.34 per cent after buying more shares in October 2025. Sales in 2025 were 132.1 billion won, of which 25.9 billion won were exports.

Neopharm: full profile, brands and acquisition history →

🇰🇷 REALBARRIER and other South Korean brands

Brandtree records a controlling owner for 237 brands that began in South Korea. 12 of them (5%) are now controlled by a company headquartered in another country; REALBARRIER is not one of them.

All South Korean brands and who owns them →

Frequently asked questions

Who is the parent company of REALBARRIER?

The parent company of REALBARRIER is Neopharm, a publicly listed company headquartered in South Korea.

Is REALBARRIER South Korean?

Yes. REALBARRIER originated in South Korea and its owner, Neopharm, is also headquartered in South Korea.

Is REALBARRIER still owned by Neopharm?

Yes. As of 28 October 2026, REALBARRIER is still owned by Neopharm. The ownership record was last checked against primary sources on that date.

Sources (2) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] NeoPharm Co., Ltd. Business Report (사업보고서) for fiscal year 2025, filed with DART — NeoPharm Co., Ltd., Stock exchange filing, published 16 March 2026; retrieved 28 October 2026.
  2. [2] 리얼베리어 REALBARRIER – 피부장벽 전문 더모코스메틱 | 네오팜 — NeoPharm Co., Ltd., Official document; retrieved 28 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.